- Home
- THRD vs NRC Comparison
THRD vs NRC Comparison
Compare THRD & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- NRC
- Stock Information
- Founded
- THRD 2019
- NRC 1981
- Country
- THRD United States
- NRC United States
- Employees
- THRD N/A
- NRC N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- THRD Health Care
- NRC Health Care
- Exchange
- THRD Nasdaq
- NRC Nasdaq
- Market Cap
- THRD 513.2M
- NRC 426.3M
- IPO Year
- THRD 2022
- NRC N/A
- Fundamental
- Price
- THRD $11.45
- NRC $19.46
- Analyst Decision
- THRD Strong Buy
- NRC
- Analyst Count
- THRD 3
- NRC 0
- Target Price
- THRD $20.33
- NRC N/A
- AVG Volume (30 Days)
- THRD 218.2K
- NRC 83.2K
- Earning Date
- THRD 11-07-2024
- NRC 10-25-2024
- Dividend Yield
- THRD N/A
- NRC 2.51%
- EPS Growth
- THRD N/A
- NRC N/A
- EPS
- THRD N/A
- NRC 1.12
- Revenue
- THRD N/A
- NRC $144,155,000.00
- Revenue This Year
- THRD N/A
- NRC N/A
- Revenue Next Year
- THRD N/A
- NRC N/A
- P/E Ratio
- THRD N/A
- NRC $16.70
- Revenue Growth
- THRD N/A
- NRC N/A
- 52 Week Low
- THRD $7.08
- NRC $17.62
- 52 Week High
- THRD $16.94
- NRC $42.19
- Technical
- Relative Strength Index (RSI)
- THRD 40.06
- NRC 50.39
- Support Level
- THRD $10.10
- NRC $18.33
- Resistance Level
- THRD $12.49
- NRC $21.64
- Average True Range (ATR)
- THRD 1.30
- NRC 0.79
- MACD
- THRD -0.32
- NRC 0.01
- Stochastic Oscillator
- THRD 25.00
- NRC 38.24
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.